{"id":"NCT00538902","sponsor":"Abbott","briefTitle":"Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate","officialTitle":"A Multi-center Randomized, Phase 2/3, Double-blind, Parallel-group, Placebo-controlled Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-08","primaryCompletion":"2008-07","completion":"2009-12","firstPosted":"2007-10-03","resultsPosted":"2009-12-30","lastUpdate":"2011-04-11"},"enrollment":302,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Adalimumab 80 mg","otherNames":["Humira"]},{"type":"BIOLOGICAL","name":"Adalimumab 40 mg","otherNames":["Humira"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Adalimumab 80 mg","type":"EXPERIMENTAL"},{"label":"Adalimumab 40 mg","type":"EXPERIMENTAL"}],"summary":"A study to assess the safety and efficacy of adalimumab administered as a subcutaneous injection in adult Chinese subjects with rheumatoid arthritis and treated with methotrexate","primaryOutcome":{"measure":"Number of Participants With American College of Rheumatology (ACR)20 at Week 12 of the Double-Blind Period","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":21,"sd":null},{"arm":"Adalimumab 40 mg","deltaMin":69,"sd":null},{"arm":"Adalimumab 80 mg","deltaMin":62,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.026"},{"comp":"OG000 vs OG001","p":"0.004"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":11,"countries":["China"]},"refs":{"pmids":["27338778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Injection site pruritus"]}}